Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Policy Medicare Medicaid

US Medicare Agency Makes It Easier For Texas Suppliers To Replace DME Lost To Winter Storms

Executive Summary

Durable medical equipment suppliers get temporary HHS and CMS waivers to help Texas Medicare and Medicaid beneficiaries due to the state’s winter storm.

You may also be interested in...



White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency

At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.

Former J&J VP Elizabeth Fowler Tapped To Lead CMS Innovation Center

Elizabeth Fowler of the Commonwealth Fund will likely lead the CMS Innovation Center, which tests health care payment systems.

Table

View full table

Topics

Tags:
Policy Medicare Medicaid
Latest News

Minute Insight: Acutus Adds Another Device To The Left-Heart Business It Sold To Medtronic

How Europe’s Nomenclature System Works And Offers New Insights

MHRA Offers Medtechs Extra Transition Time For UK Regulatory System Compliance

For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component

UsernamePublicRestriction

Register

MT143541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By